Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study

Kieran L. Quinn (), Erin M. Macdonald, Tara Gomes, Muhammad M. Mamdani, Anjie Huang and David N. Juurlink
Additional contact information
Kieran L. Quinn: University of Toronto
Erin M. Macdonald: Institute for Clinical Evaluative Sciences
Tara Gomes: Institute for Clinical Evaluative Sciences
Muhammad M. Mamdani: Institute for Clinical Evaluative Sciences
Anjie Huang: Institute for Clinical Evaluative Sciences
David N. Juurlink: Institute for Clinical Evaluative Sciences

Drug Safety, 2017, vol. 40, issue 9, No 9, 835-840

Abstract: Abstract Introduction Digoxin is commonly prescribed to elderly patients with heart failure and atrial fibrillation, and macrolide antibiotics markedly increase the risk of digoxin toxicity. Objective The aim was to determine whether, in older patients receiving digoxin, macrolide antibiotics are associated with sudden death. Methods We used a population-based, nested, case–control design from January 1, 1994 to December 31, 2012 in a cohort of Ontario residents aged 66 years or older prescribed digoxin. The primary outcome was the risk of sudden death within 14 days of exposure to one of three antibiotics (erythromycin, clarithromycin, or azithromycin), relative to cefuroxime. Results Among 39,072 Ontarians who died suddenly while receiving digoxin, 586 died within 14 days of receiving a study antibiotic. Relative to cefuroxime, we found no statistically significant increase in the risk of sudden death following treatment with erythromycin [adjusted odds ratio (aOR) 0.98; 95% confidence interval (CI) 0.65–1.48], clarithromycin (aOR 1.25; 95% CI 0.94–1.65), or azithromycin (aOR 1.07; 95% CI 0.75–1.53). Conclusion This finding reinforces the cardiovascular safety of macrolide antibiotics in a high-risk population.

Keywords: Digoxin; Sudden Death; Clarithromycin; Azithromycin; Index Date (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-017-0539-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0539-9

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-017-0539-9

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().